Primary Record
celecoxib
- In stock
- 1,819 g
- Purity
- 98.1 %
- CAS
- 169590-42-5
Compound Identifiers & Properties
- CAS
- 169590-42-5
- PubChem CID
- 2662
- SMILES
- CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
- Canonical SMILES
- Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1
Names & Synonyms
- celecoxib
- Celebrex
- Celebra
- 169590-42-5
- Onsenal
- Celocoxib
- Celecox
- Xilebao
- Celecoxibum
- Celecoxi
- Eurocox
- Solexa
- Celecoxib [USAN]
- Celecixib
- Celecoxib-d4
- Celecoxib-d7
- Medicoxib
- Msdicoxib
- Xileba
- Celecoxib?
- Celecoxib RS
- Celebrex (TN)
- Celecoxib CRS
- ELYXYB-celecoxib
- ELYXYB
- Celecoxib 50 mg
- Celecoxib (GMP)
- Celecoxib [Old RN]
- Celebra (TN)
- Onsenal (TN)
- Celecoxib 100 mg
- Celecoxib 200 mg
- Celecoxib 400 mg
- CELEBCOXIB
- Celecoxib (GMP Like)
- Celecoxib (Standard)
- SC-58635
- C17H14F3N3O2S
- YM177
- DFN15
- JCX84Q7J1L
- RefChem:5656
- Spectrum_000432
- 1oq5
- CelecoxibSC 58635
- CELECOXIB [INN]
- CELECOXIB [JAN]
- CHEMBL118
- UNII-JCX84Q7J1L
- CELECOXIB [MI]
- MFCD00941298
- YM 177
- CELECOXIB [HSDB]
- HSDB 7038
- SC 58635
- Pfizer brand of celecoxib
- Spectrum2_001576
- Spectrum3_001996
- Spectrum4_000182
- Spectrum5_001324
- CELECOXIB [VANDF]
- DFN-15
- Celecoxib (SC-58635)
- RZEKVGVHFLEQIL-UHFFFAOYSA-N
- Celecoxib [USAN:INN:BAN]
- DTXSID0022777
- CELECOXIB [MART.]
- CHEBI:41423
- D03RTS
- Epitope ID:613421
- AC1L1E6K
- CELECOXIB [USP-RS]
- CELECOXIB [WHO-DD]
- Celecoxib/Celebrex, Celebra
- cid_2662
- SCHEMBL3708
- CCRIS 9330
- DTXCID502777
- SC58635
- BSPBio_003596
- Celebrex, Celebra, Celecoxib
- CELECOXIB [EMA EPAR]
- KBioGR_000723
- KBioGR_002351
- KBioSS_000912
- KBioSS_002354
- cc-518
- Celecoxib (JAN/USAN/INN)
- MLS001165684
- MLS001195656
- MLS001304708
- MLS006011862
- BIDD:GT0408
- DivK1c_000893
- NSC-719627
- NSC-758624
- SPECTRUM1503678
- 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
- Celecoxib - Bio-X trade mark
- SPBio_001512
- TPI-336
- 4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE
- Celecoxib (JP18/USP/INN)
- Celecoxib, 98% - 1g 1g
- 184007-95-2
- CCRIS 8679
- CONSENSI COMPONENT CELECOXIB
- GTPL2892
- orb1310585
- CELECOXIB [ORANGE BOOK]
- CELECOXIB [EP MONOGRAPH]
- BDBM11639
- CTK8H4475
- ERK5-4I11
- HMS502M15
- KBio1_000893
- KBio2_000912
- KBio2_002351
- KBio2_003480
- KBio2_004919
- KBio2_006048
- KBio2_007487
- KBio3_002830
- KBio3_003037
- CELECOXIB [USP MONOGRAPH]
- CID2662
- EX-A175
- L01XX33
- M01AH01
- MSK8005
- SYN3015
- AI-525
- CEP-33222
- cMAP_000027
- NINDS_000893
- NSC719627
- YM-177
- BCPP000290
- Elyxyb (DFN-15; oral solution)
- GLXC-05108
- HMS1922G14
- HMS2089L18
- HMS2093I07
- HMS2234N18
- HMS3259L08
- HMS3261A14
- HMS3373A09
- HMS3654H09
- HMS3715F11
- HMS3867I03
- HMS3884M07
- HMS5079P03
- HY-14398GL
- Pharmakon1600-01503678
- 4-tert-butylphenethyl isothiocyanate
- ACT02648
- ALBB-033772
- BCP02156
- CID:2662
- EBD24636
- KS-00000FW2
- p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide
- UWA68620
- UWA68621
- ZINC2570895
- Tox21_111135
- Tox21_201964
- Tox21_300599
- Tox21_500406
- US8741944, Comparative Compound
- ABP000291
- BBL029086
- CCG-39354
- EBC-06063
- HY-14398G
- HY-14398R
- NCGC00091455-01
- NSC758624
- s1261
- STL373576
- Celecoxib 1.0 mg/ml in Acetonitrile
- AKOS015842517
- Tox21_111135_1
- AC-4228
- ACN-029560
- AM84588
- AT-3762
- BCP9000507
- Celebrex, Celebra, 169590-42-5
- CS-0570
- DB00482
- FC11300
- KS-1041
- NC00708
- NSC 719627
- NSC 758624
- RL02184
- SB19318
- 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide
- C17-H14-F3-N3-O2-S
- IDI1_000893
- NCGC00091455-02
- NCGC00091455-03
- NCGC00091455-04
- NCGC00091455-05
- NCGC00091455-06
- NCGC00091455-07
- NCGC00091455-08
- NCGC00091455-09
- NCGC00091455-13
- NCGC00254540-01
- NCGC00259513-01
- NCGC00261091-01
- AK-60967
- AN-12211
- BC164295
- BC209720
- BP-30217
- CPD000550473
- HY-14398
- LS-31667
- NCI60_041049
- SAM002589995
- SC-50829
- SC-58553, SC-58635
- SMR000550473
- SY064976
- 2-CHLORO-5-NITROPHENYLBORONIC ACID
- 4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
- SBI-0051875.P002
- SID:283537511
- 194044-54-7
- AB0012055
- J833.239H
- TL8001323
- UNM-0000305813
- A1664
- C2816
- CAS-169590-42-5
- CS-0901612
- FT-0601628
- FT-0623536
- FT-0700357
- NS00002556
- SW199611-3
- 4-(5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
- 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonami de
- A10193
- A25046
- C-6317
- C07589
- D00567
- EN300-119504
- J10035
- AB00052396-07
- AB00052396-08
- AB00052396-09
- AB00052396_10
- AB00052396_11
- benzenesulfonamide, 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-
- 590C425
- C105934
- Q408801
- SR-01000837528
- 4-[5-(p-tolyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
- Benzenesulfonamide,4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-
- I01-1033
- SR-01000837528-2
- SR-01000837528-3
- BRD-K02637541-001-02-4
- BRD-K02637541-001-06-5
- BRD-K02637541-001-17-2
- BRD-K02637541-001-18-0
- 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide
- D000068579
- Z1258938406
- B0084-451901
- Benzenesulfonamide, 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)-
- CELECOXIB >98.0%(HPLC) 169590-42-5 200MG
- CELECOXIB >98.0%(HPLC)(T) 169590-42-5 1G
- Celecoxib, European Pharmacopoeia (EP) Reference Standard
- 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1Hpyrazol-1-yl] benzenesulfonamide
- 4-[5-(4-Methylphenyl)-3-trifluoromethyl)-1H-pyrazol-yl]benzenesulfonamide
- CEL
- Celecoxib, United States Pharmacopeia (USP) Reference Standard
- 4-[5-(p-Tolyl)-3-(trifluoromethyl)-1-pyrazolyl]benzenesulfonamide
- Benzenesulfonamide,4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)
- 1-(4-Aminosulfonylphenyl)-3-trifluoromethyl-5-(4-methylphenyl)-1H-pyrazole
- 1-(4-Sulfamoylphenyl)-3-(trifluoromethyl)-5-(4-methylphenyl)-1H-pyrazole
- 4-(5-(4-Methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide
- 4-(5-p-tolyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
- 4-[3-(Trifluoromethyl)-5-(p-tolyl)-1H-pyrazol-1-yl]benzenesulfonamide
- 4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-pyrazol-1-yl]benzenesulfonamide
- 4-[5-(4-Methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulphonamide
- 4-[5-(4-Methylphenyl)-3-trifluoromethyl-1H-pyrazol-1-yl]benzenesulfonamide
- 5-(4-Methylphenyl)-1-(4-sulfamoylphenyl)-3-(trifluoromethyl)pyrazole
- 544686-20-6
- 544686-21-7
- Celecoxib, Pharmaceutical Secondary Standard; Certified Reference Material
- 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzene-1-sulfonamide
- 4-[3-(Trifluoromethyl)-5-(4-methylphenyl)-1H-pyrazole-1-yl]benzenesulfonamide
- 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyazol-1-yl]benezenesulfonamide
- Protein hydrolyzates,silk, [2-hydroxy-3-(trimethylammonio)propyl], chlorides
- SC-58635; SC 58635; SC58635; YM-177; YM 177; YM177;Celebrex;Celebra
- 1000343-91-8
- 169590-61-8
- 4-[5-(4-Methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide =98.0% (by HPLC, titration analysis)
- 685-962-5
- 733809-45-5
- CLX
- CXB